BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 33332384)

  • 1. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes.
    Byrjalsen A; Hansen TVO; Stoltze UK; Mehrjouy MM; Barnkob NM; Hjalgrim LL; Mathiasen R; Lautrup CK; Gregersen PA; Hasle H; Wehner PS; Tuckuviene R; Sackett PW; Laspiur AO; Rossing M; Marvig RL; Tommerup N; Olsen TE; Scheie D; Gupta R; Gerdes AM; Schmiegelow K; Wadt K
    PLoS Genet; 2020 Dec; 16(12):e1009231. PubMed ID: 33332384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.
    Goudie C; Witkowski L; Cullinan N; Reichman L; Schiller I; Tachdjian M; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Clark ME; Clinton C; Coltin H; Felton K; Fernandez CV; Fleming AJ; Fuentes-Bolanos N; Gibson P; Grant R; Hammad R; Harrison LW; Irwin MS; Johnston DL; Kane S; Lafay-Cousin L; Lara-Corrales I; Larouche V; Mathews N; Meyn MS; Michaeli O; Perrier R; Pike M; Punnett A; Ramaswamy V; Say J; Somers G; Tabori U; Thibodeau ML; Toupin AK; Tucker KM; van Engelen K; Vairy S; Waespe N; Warby M; Wasserman JD; Whitlock JA; Sinnett D; Jabado N; Nathan PC; Shlien A; Kamihara J; Deyell RJ; Ziegler DS; Nichols KE; Dendukuri N; Malkin D; Villani A; Foulkes WD
    JAMA Oncol; 2021 Dec; 7(12):1806-1814. PubMed ID: 34617981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.
    Brozou T; Taeubner J; Velleuer E; Dugas M; Wieczorek D; Borkhardt A; Kuhlen M
    Eur J Pediatr; 2018 Jan; 177(1):53-60. PubMed ID: 28929227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes.
    Hebert R; Cullinan N; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Coltin H; Deyell RJ; Felton K; Fernandez CV; Fleming AJ; Gibson P; Hammad R; Jabado N; Johnston DL; Lafay-Cousin L; Larouche V; Leblanc-Desrochers C; Michaeli O; Perrier R; Pike M; Say J; Schiller I; Toupin AK; Vairy S; van Engelen K; Waespe N; Villani A; Foulkes WD; Malkin D; Reichman L; Goudie C
    J Med Genet; 2023 Nov; 60(12):1218-1223. PubMed ID: 37460202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-Onset Cancer Predisposition Syndromes in Children and Adolescents-To Test or not to Test?
    Kratz CP; Lupo PJ; Zelley K; Schienda J; Nichols KE; Stewart DR; Malkin D; Brodeur GM; Maxwell K; Plon SE; Walsh MF
    Clin Cancer Res; 2024 May; 30(9):1733-1738. PubMed ID: 38411636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors.
    Goudie C; Cullinan N; Villani A; Mathews N; van Engelen K; Malkin D; Irwin MS; Foulkes WD
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27390. PubMed ID: 30117275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients.
    Schroeder C; Faust U; Krauße L; Liebmann A; Abele M; Demidov G; Schütz L; Kelemen O; Pohle A; Gauß S; Sturm M; Roggia C; Streiter M; Buchert R; Armenau-Ebinger S; Nann D; Beschorner R; Handgretinger R; Ebinger M; Lang P; Holzer U; Skokowa J; Ossowski S; Haack TB; Mau-Holzmann UA; Dufke A; Riess O; Brecht IB
    Eur J Hum Genet; 2023 Oct; 31(10):1139-1146. PubMed ID: 37507557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors.
    Hansford JR; Das A; McGee RB; Nakano Y; Brzezinski J; Scollon SR; Rednam SP; Schienda J; Michaeli O; Kim SY; Greer MC; Weksberg R; Stewart DR; Foulkes WD; Tabori U; Pajtler KW; Pfister SM; Brodeur GM; Kamihara J
    Clin Cancer Res; 2024 Jun; 30(11):2342-2350. PubMed ID: 38573059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline whole genome sequencing in adults with multiple primary tumors.
    Wang Y; Ding Q; Prokopec S; Farncombe KM; Bruce J; Casalino S; McCuaig J; Szybowska M; van Engelen K; Lerner-Ellis J; Pugh TJ; Kim RH
    Fam Cancer; 2023 Oct; 22(4):513-520. PubMed ID: 37481477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management.
    McGee RB; Oak N; Harrison L; Xu K; Nuccio R; Blake AK; Mostafavi R; Lewis S; Taylor LM; Kubal M; Ouma A; Hines-Dowell SJ; Cheng C; Furtado LV; Nichols KE
    Clin Cancer Res; 2023 Apr; 29(7):1243-1251. PubMed ID: 36693186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel.
    Byrjalsen A; Diets IJ; Bakhuizen J; Hansen TVO; Schmiegelow K; Gerdes AM; Stoltze U; Kuiper RP; Merks JHM; Wadt K; Jongmans M
    Fam Cancer; 2021 Oct; 20(4):279-287. PubMed ID: 34061292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
    Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal germline testing among patients with colorectal cancer: clinical actionability and optimised panel.
    Jiang W; Li L; Ke CF; Wang W; Xiao BY; Kong LH; Tang JH; Li Y; Wu XD; Hu Y; Guo WH; Wang SZ; Wan DS; Xu RH; Pan ZZ; Ding PR
    J Med Genet; 2022 Apr; 59(4):370-376. PubMed ID: 33563768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
    Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
    BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An eHealth decision-support tool to prioritize referral practices for genetic evaluation of patients with Wilms tumor.
    Cullinan N; Villani A; Mourad S; Somers GR; Reichman L; van Engelen K; Stephens D; Weksberg R; Foulkes WD; Malkin D; Grant R; Goudie C
    Int J Cancer; 2020 Feb; 146(4):1010-1017. PubMed ID: 31286500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic testing of BRCA1, BRCA2 and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels.
    Feliubadaló L; López-Fernández A; Pineda M; Díez O; Del Valle J; Gutiérrez-Enríquez S; Teulé A; González S; Stjepanovic N; Salinas M; Capellá G; Brunet J; Lázaro C; Balmaña J;
    Int J Cancer; 2019 Nov; 145(10):2682-2691. PubMed ID: 30927264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings.
    Seifert BA; O'Daniel JM; Amin K; Marchuk DS; Patel NM; Parker JS; Hoyle AP; Mose LE; Marron A; Hayward MC; Bizon C; Wilhelmsen KC; Evans JP; Earp HS; Sharpless NE; Hayes DN; Berg JS
    Clin Cancer Res; 2016 Aug; 22(16):4087-4094. PubMed ID: 27083775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
    Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
    Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of clinically relevant germline variants detected by next-generation sequencing in patients with childhood cancer: a review of the literature.
    Sylvester DE; Chen Y; Jamieson RV; Dalla-Pozza L; Byrne JA
    J Med Genet; 2018 Dec; 55(12):785-793. PubMed ID: 30287599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive germline-genomic and clinical profiling in 160 unselected children and adolescents with cancer.
    Wagener R; Taeubner J; Walter C; Yasin L; Alzoubi D; Bartenhagen C; Attarbaschi A; Classen CF; Kontny U; Hauer J; Fischer U; Dugas M; Kuhlen M; Borkhardt A; Brozou T
    Eur J Hum Genet; 2021 Aug; 29(8):1301-1311. PubMed ID: 33840814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.